From Concept to Clinic: Targeting the Nitric Oxide-Soluble Guanylate Cyclase-cGMP Pathway for Neurodegenerative Diseases

Time: 2:30 pm
day: Track B - Day 1 PM


  • Unlocking the full therapeutic potential of the nitric oxide-soluble guanylate cyclase-cGMP signaling pathway in the brain
  • Demonstrating successful clinical translation of sGC stimulation for CNS drug development
  • Exploring the benefits of incorporating objective biomarkers in early clinical development